<?xml version="1.0" encoding="UTF-8" standalone="no"?>
<!DOCTYPE article PUBLIC "-//NLM//DTD Journal Publishing DTD v2.3 20070202//EN" "journalpublishing.dtd">
<article xml:lang="EN" xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" article-type="case-report">
<front>
<journal-meta>
<journal-id journal-id-type="publisher-id">Front. Med.</journal-id>
<journal-title>Frontiers in Medicine</journal-title>
<abbrev-journal-title abbrev-type="pubmed">Front. Med.</abbrev-journal-title>
<issn pub-type="epub">2296-858X</issn>
<publisher>
<publisher-name>Frontiers Media S.A.</publisher-name>
</publisher>
</journal-meta>
<article-meta>
<article-id pub-id-type="doi">10.3389/fmed.2022.1063681</article-id>
<article-categories>
<subj-group subj-group-type="heading">
<subject>Medicine</subject>
<subj-group>
<subject>Case Report</subject>
</subj-group>
</subj-group>
</article-categories>
<title-group>
<article-title>Case report: Acute oxalate nephropathy due to traditional medicinal herbs</article-title>
</title-group>
<contrib-group>
<contrib contrib-type="author">
<name><surname>Wang</surname> <given-names>Lirui</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/1575847/overview"/>
</contrib>
<contrib contrib-type="author">
<name><surname>Zhu</surname> <given-names>Zhuxian</given-names></name>
<uri xlink:href="http://loop.frontiersin.org/people/2110119/overview"/>
</contrib>
<contrib contrib-type="author" corresp="yes">
<name><surname>Li</surname> <given-names>Jiangtao</given-names></name>
<xref ref-type="corresp" rid="c001"><sup>&#x002A;</sup></xref>
<uri xlink:href="http://loop.frontiersin.org/people/2042345/overview"/>
</contrib>
</contrib-group>
<aff><institution>Department of Nephrology, Tongji Hospital, Tongji University School of Medicine</institution>, <addr-line>Shanghai</addr-line>, <country>China</country></aff>
<author-notes>
<fn fn-type="edited-by"><p>Edited by: Sree Bhushan Raju, Nizam&#x2019;s Institute of Medical Sciences, India</p></fn>
<fn fn-type="edited-by"><p>Reviewed by: Faizan Ahmed Ansari, Ansari Hospital, India; Ravi Tej Madipalli, Nizam&#x2019;s Institute of Medical Sciences, India</p></fn>
<corresp id="c001">&#x002A;Correspondence: Jiangtao Li, <email>lijiangtaosuyan@126.com</email></corresp>
<fn fn-type="other" id="fn004"><p>This article was submitted to Nephrology, a section of the journal Frontiers in Medicine</p></fn>
</author-notes>
<pub-date pub-type="epub">
<day>01</day>
<month>12</month>
<year>2022</year>
</pub-date>
<pub-date pub-type="collection">
<year>2022</year>
</pub-date>
<volume>9</volume>
<elocation-id>1063681</elocation-id>
<history>
<date date-type="received">
<day>07</day>
<month>10</month>
<year>2022</year>
</date>
<date date-type="accepted">
<day>17</day>
<month>11</month>
<year>2022</year>
</date>
</history>
<permissions>
<copyright-statement>Copyright &#x00A9; 2022 Wang, Zhu and Li.</copyright-statement>
<copyright-year>2022</copyright-year>
<copyright-holder>Wang, Zhu and Li</copyright-holder>
<license xlink:href="http://creativecommons.org/licenses/by/4.0/"><p>This is an open-access article distributed under the terms of the Creative Commons Attribution License (CC BY). The use, distribution or reproduction in other forums is permitted, provided the original author(s) and the copyright owner(s) are credited and that the original publication in this journal is cited, in accordance with accepted academic practice. No use, distribution or reproduction is permitted which does not comply with these terms.</p></license>
</permissions>
<abstract>
<p>Acute oxalate nephropathy (AON), defined as the association between acute kidney injury (AKI) and the deposition of oxalate crystals in the renal parenchyma, is a rare complication of hyperoxaluria. We report a rare case of AON in an adult due to medicinal herbs intake leading to crystal-induced AKI. We recommend that a thorough medication history including the use of medicinal herbs, should be obtained for all patients with a rapid loss of kidney function, especially in the absence of known risk factors for AKI. The use of medicinal herbs with unknown oxalate contents would increase the risk of AON and should be avoided.</p>
</abstract>
<kwd-group>
<kwd>acute kidney injury</kwd>
<kwd>acute oxalate nephropathy</kwd>
<kwd>medicinal herbs</kwd>
<kwd>hyperoxaluria</kwd>
<kwd>renal biopsy</kwd>
</kwd-group>
<counts>
<fig-count count="1"/>
<table-count count="1"/>
<equation-count count="0"/>
<ref-count count="24"/>
<page-count count="5"/>
<word-count count="2564"/>
</counts>
</article-meta>
</front>
<body>
<sec id="S1" sec-type="intro">
<title>Introduction</title>
<p>Oxalate is originated endogenously from the metabolism of amino acids or exogenously from the intake of oxalate-rich foods (<xref ref-type="bibr" rid="B1">1</xref>). The kidney is the sole organ responsible for oxalate excretion (<xref ref-type="bibr" rid="B2">2</xref>). Excessive oxalate in the kidney causes the formation of insoluble calcium oxalate crystals (<xref ref-type="bibr" rid="B3">3</xref>). This, in turn, leads to a spectrum of kidney disorders, including nephrolithiasis, nephrocalcinosis, and acute oxalate nephropathy (AON) (<xref ref-type="bibr" rid="B4">4</xref>). AON can be observed with primary hyperoxaluria (PH) (<xref ref-type="bibr" rid="B5">5</xref>) and secondary hyperoxaluria (SH) (<xref ref-type="bibr" rid="B6">6</xref>), with the first being inborn errors of metabolism and the second a result of enteric hyperoxaluria or excessive oxalate intake.</p>
<p>Here, we describe a case of acute kidney injury (AKI) after excessive ingestion of Chinese medicinal herbs with previously normal renal function, with tubular deposition of oxalate crystals evident on renal biopsy.</p>
</sec>
<sec id="S2">
<title>Case</title>
<p>A 25-year-old male patient presented to the emergency room with recurrent episodes of lumbar pain, nausea, and vomiting in the preceding days. The patient was healthy and had no previous medical problems. A family history of urolithiasis was not noted. Laboratory workup revealed non-oliguric AKI with a serum creatinine of 237 &#x03BC;mol/L, elevated from a stable baseline of 84 &#x03BC;mol/L. Post-renal causes were excluded because the renal ultrasound did not show any signs of obstructive nephropathy or intra-renal or ureteral concrements. The patient was transferred to the nephrology department for further evaluation.</p>
<p>Except for the bilateral costovertebral angle and lower abdominal tenderness, the rest of the physical examination findings were unremarkable. Renal function was severely deteriorated with serum creatinine levels of 724 &#x03BC;mol/L and urea nitrogen level of 21.75 mmol/L. Electrolytes showed potassium of 4.86 mmol/L and sodium of 136 mmol/L. Laboratory findings demonstrated that parathyroid functions were within the normal range: calcium 2.41 mmol/L, phosphorus 1.43 mmol/L, and intact parathyroid hormone (PTH) 38.45 pg/ml (15&#x2013;65 pg/ml). The liver function test results were unremarkable. Serological test revealed normal levels of immunoglobulin, complements and antinuclear antibodies. ANCA-antibodies and anti-GBM-antibodies were negative. His 24-h urine protein collection was normal (0.08 g/24 h), but the urine albumin-to-creatinine ratio was slightly elevated at 8.16 mg/mmol. Abdominal computed tomography (CT) were normal.</p>
<p>The calculated fractional excretion of sodium (FeNa) was 1.6% and renal function did not improve upon intravenous volume challenge. As such, pre-renal AKI is unlikely. Since the etiology of AKI remains unknown, a renal biopsy was performed, which showed features of severe acute tubular necrosis without infiltration of inflammatory cells. Abundant tubular calcium oxalate deposits were detected within the tubular lumen (<xref ref-type="fig" rid="F1">Figure 1</xref>). Additional laboratory tests revealed elevated urinary oxalate excretion (1.11 mmol/24 h). Mutations in AGXT, GRHPR, and HOGA1 in PH were not detected (<xref ref-type="bibr" rid="B7">7</xref>) (<xref ref-type="supplementary-material" rid="DS1">Supplementary Appendix 1</xref>).</p>
<fig id="F1" position="float">
<label>FIGURE 1</label>
<caption><p>Renal biopsy specimen with arrow showing a couple of calcium oxalate deposits within renal tubules. <bold>(A)</bold> HE staining, 400&#x00D7; magnification. <bold>(B)</bold> Polarized light, 400&#x00D7; magnification.</p></caption>
<graphic mimetype="image" mime-subtype="tiff" xlink:href="fmed-09-1063681-g001.tif"/>
</fig>
<p>Upon further questioning, the patient reported an ingestion of approximately 30 g (dry weight) of a mixture of several herbs (<italic>Panax notoginseng, Clematis chinensis Osbeck, Szechwan Lovage Rhizome, borneol, safflower</italic>, and <italic>Eupolyphaga sinensis</italic>) per day in the last 4 weeks before admission for ankle sprain. This traditional remedy is in powder form and mixed with water. He said that the ingestion of such remedies was a customary practice in his hometown. Consumption of vitamin C or ethylene glycol was ruled out.</p>
<p>Elevated urine oxalate levels and renal biopsy led to the diagnosis of oxalate nephropathy, which is the most likely cause of AKI. Given the lack of other explanations, hyperoxaluria was believed to be due to excessive intake of oxalate-rich herbs.</p>
<p>Due to uremic symptoms, emergent hemodialysis <italic>via</italic> a temporary catheter was started before renal biopsy. Totally, three standard hemodialysis were conducted on an Artis hemodialysis machine (Gambro Lundia AB, Lund, Sweden) with a low-flux polysulphon dialyzer F6 (Fresenius Medical Care, Bad Hamburg, Germany). Serum creatinine peaked at 211 &#x03BC;mol/L before plateauing with cessation of dialysis. Once the diagnosis is established, the patient was advised to avoid a high oxalate diet, drink plenty of water (&#x003E;3 L/1.73 m<sup>2</sup>) and consume calcium acetate (1,334 mg orally with each meal), and potassium citrate (2 g/day, orally). By the day of discharge, renal function had partially recovered, and creatinine levels had decreased to 137 &#x03BC;mol/L. His creatinine level improved and plateaued at 103 &#x03BC;mol/L at 12 months follow-up. <xref ref-type="table" rid="T1">Table 1</xref> describes the renal function tests of the patient.</p>
<table-wrap position="float" id="T1">
<label>TABLE 1</label>
<caption><p>Trend in renal function panel and clinical therapy review.</p></caption>
<table cellspacing="5" cellpadding="5" frame="hsides" rules="groups">
<thead>
<tr>
<td valign="top" align="left">Timeline line</td>
<td valign="top" align="center">Day 0 (admission)</td>
<td valign="top" align="center">Day 1</td>
<td valign="top" align="center">Day 2</td>
<td valign="top" align="center">Day 3</td>
<td valign="top" align="center">Day 5</td>
<td valign="top" align="center">Day 6</td>
<td valign="top" align="center">Day 7</td>
<td valign="top" align="center">Day 10</td>
<td valign="top" align="center">Day 13 (discharge)</td>
<td valign="top" align="center">1 months after discharge</td>
<td valign="top" align="center">3 months after discharge</td>
<td valign="top" align="center">6 months after discharge</td>
<td valign="top" align="center">12 months after discharge</td>
</tr>
</thead>
<tbody>
<tr>
<td valign="top" align="left">Serum creatinine (&#x03BC;mol/L)</td>
<td valign="top" align="center">724</td>
<td valign="top" align="center">925</td>
<td/>
<td/>
<td valign="top" align="center">508</td>
<td/>
<td valign="top" align="center">211</td>
<td valign="top" align="center">171</td>
<td valign="top" align="center">137</td>
<td valign="top" align="center">101</td>
<td valign="top" align="center">103</td>
<td valign="top" align="center">100</td>
<td valign="top" align="center">103</td>
</tr>
<tr>
<td valign="top" align="left">Blood urea nitrogen (mmol/L)</td>
<td valign="top" align="center">21.75</td>
<td valign="top" align="center">21.8</td>
<td/>
<td/>
<td valign="top" align="center">16.54</td>
<td/>
<td valign="top" align="center">6.5</td>
<td valign="top" align="center">6.35</td>
<td valign="top" align="center">6.8</td>
<td valign="top" align="center">3.80</td>
<td valign="top" align="center">4.37</td>
<td valign="top" align="center">5.72</td>
<td valign="top" align="center">5.41</td>
</tr>
<tr>
<td valign="top" align="left">eGFR (ml/min/1.73 m<sup>2</sup>)</td>
<td valign="top" align="center"/><td valign="top" align="center">8.2</td>
<td/>
<td/>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="center">60.2</td>
<td valign="top" align="center">88.3</td>
<td valign="top" align="center">86.8</td>
<td valign="top" align="center">89.3</td>
<td valign="top" align="center">85</td>
</tr>
<tr>
<td valign="top" align="left" colspan="13"><bold>(CKD-EPI equation)</bold></td>
<td valign="top" align="center"/></tr>
<tr>
<td valign="top" align="left">Renal biopsy</td>
<td valign="top" align="center"/><td/>
<td/>
<td valign="top" align="center">&#x221A;</td>
<td/>
<td/>
<td/>
<td/>
<td valign="top" align="center"/><td valign="top" align="center"/><td valign="top" align="center"/><td valign="top" align="center"/><td valign="top" align="center"/></tr>
<tr>
<td valign="top" align="left">Oxalate binder therapy</td>
<td valign="top" align="center"/><td/>
<td/>
<td/>
<td valign="top" align="center">CA #</td>
<td valign="top" align="center">CA #</td>
<td valign="top" align="center">CA #</td>
<td valign="top" align="center">CA #</td>
<td valign="top" align="center">CA #</td>
<td valign="top" align="center">CA #</td>
<td valign="top" align="center"/><td valign="top" align="center"/><td valign="top" align="center"/></tr>
<tr>
<td valign="top" align="left"/><td valign="top" align="center"/><td/>
<td/>
<td/>
<td valign="top" align="center">PC<xref ref-type="table-fn" rid="t1fns1">&#x002A;</xref></td>
<td valign="top" align="center">PC<xref ref-type="table-fn" rid="t1fns1">&#x002A;</xref></td>
<td valign="top" align="center">PC<xref ref-type="table-fn" rid="t1fns1">&#x002A;</xref></td>
<td valign="top" align="center">PC<xref ref-type="table-fn" rid="t1fns1">&#x002A;</xref></td>
<td valign="top" align="center">PC<xref ref-type="table-fn" rid="t1fns1">&#x002A;</xref></td>
<td valign="top" align="center">PC<xref ref-type="table-fn" rid="t1fns1">&#x002A;</xref></td>
<td valign="top" align="center"/><td valign="top" align="center"/><td valign="top" align="center"/></tr>
<tr>
<td valign="top" align="left">Intermittent hemodialysis</td>
<td valign="top" align="center"/><td/>
<td valign="top" align="center">&#x221A;</td>
<td/>
<td/>
<td valign="top" align="center">&#x221A;</td>
<td valign="top" align="center">&#x221A;</td>
<td/>
<td valign="top" align="center"/><td valign="top" align="center"/><td valign="top" align="center"/><td valign="top" align="center"/><td valign="top" align="center"/></tr>
</tbody>
</table>
<table-wrap-foot>
<fn id="t1fns1"><p>CA #, calcium acetate (1334 mg orally with each meal); PC&#x002A;, potassium citrate (2 g/day). Intermittent hemodialysis was conducted using a Artis hemodialysis machine (Gambro Lundia AB, Lund, Sweden) with a low-flux polysulphon dialyzer F6 (Fresenius Medical Care, Bad Hamburg, Germany).</p></fn>
</table-wrap-foot>
</table-wrap>
</sec>
<sec id="S3" sec-type="discussion">
<title>Discussion</title>
<p>Acute oxalate nephropathy, defined as the association between AKI and the deposition of oxalate crystals in the renal parenchyma, is a rare complication of hyperoxaluria. In the present case, renal biopsy under polarized light revealed massive oxalate crystals in the tubular lumen. This highlights the importance of histopathological confirmations of AON.</p>
<p>Acute oxalate nephropathy can occur due to PH or SH (<xref ref-type="bibr" rid="B5">5</xref>, <xref ref-type="bibr" rid="B6">6</xref>). PHs comprise a group of three distinct genetic disorders of glyoxylate metabolism, characterized by endogenous oxalate overproduction (<xref ref-type="bibr" rid="B7">7</xref>). Patients with PH typically develop recurrent renal lithiasis and progressive nephrocalcinosis (<xref ref-type="bibr" rid="B8">8</xref>). Our patient had no personal history of lithiasis and the genetic testing results were normal. Thus, the clinical picture in our patient was not consistent with a diagnosis of PH.</p>
<p>Secondary hyperoxaluria is more common. The leading cause of SH is enteric hyperoxaluria (<xref ref-type="bibr" rid="B9">9</xref>), which is usually a consequence of fat malabsorption (<xref ref-type="bibr" rid="B10">10</xref>). In enteric hyperoxaluria, fat malabsorption leads to increased binding of calcium to free fatty acids, resulting in more soluble oxalates in the intestinal lumen, which are subsequently absorbed (<xref ref-type="bibr" rid="B11">11</xref>). Enteric hyperoxaluria is often present in patients with inflammatory bowel disease, celiac disease, short bowel syndrome, chronic pancreatitis, or bariatric surgery (<xref ref-type="bibr" rid="B12">12</xref>&#x2013;<xref ref-type="bibr" rid="B16">16</xref>). However, our patient showed no clinical symptoms of fat malabsorption.</p>
<p>Increased intake of dietary oxalate or oxalate precursor (such as ethylene glycol or vitamin C) can also contribute to AON (<xref ref-type="bibr" rid="B17">17</xref>&#x2013;<xref ref-type="bibr" rid="B20">20</xref>). Prior reports have described patients with oxalate nephropathy due to hyperoxaluria after ingesting oxalate-rich food (<xref ref-type="bibr" rid="B17">17</xref>, <xref ref-type="bibr" rid="B18">18</xref>). Dietary sources rich in oxalate include nuts, plums, chocolate, beetroot, strawberries, and spinach (<xref ref-type="bibr" rid="B21">21</xref>). Our patient occasionally consumed these foods. In addition, he denied the use of ethylene glycol products or consumption of vitamin C. Therefore, it is unlikely that the dietary oxalate or oxalate precursor was the culprit.</p>
<p>Traditional herbal medicines are naturally occurring, plant or animal-derived substances that are not processed to treat diseases according to local practices. In a study by Huang et al. (<xref ref-type="bibr" rid="B22">22</xref>), the total oxalate content of 22 herbs ranged from 165 to 3,204 mg/100 g, which was much higher than that of daily foods such as various flours and nuts. Different medicinal herbs, even those from the same family, contain significantly different amounts of oxalate (<xref ref-type="bibr" rid="B22">22</xref>). Oxalate nephropathy has been reported following the consumption of medicinal herbs, such as rhubarb and star fruit (<xref ref-type="bibr" rid="B23">23</xref>, <xref ref-type="bibr" rid="B24">24</xref>). In the present case, the absence of evidence for any other cause of AON incriminates the herbal mixture as the culprit. There are no previous case reports in the literature describing oxalate nephropathy in association with any of the involved herbs in our patient. The concentration of oxalate in the same herb may be quite different in different place of origin. Different parts of the same herb, even those from the same place of origin, contain significantly different amounts of oxalate. Due to the lack of detailed information, the concentration of oxalate in each herb was not tested in our study. Thus, it is not known which component of the mixture is responsible for AON. Even so, the findings from our case, at least to some extent, indicate that the use of medicinal herbs with unknown oxalate contents may increase the risk of AON.</p>
<p>We report a rare case of AON in an adult due to medicinal herbs intake leading to crystal-induced AKI. We recommend that a thorough medication history including the use of medicinal herbs, should be obtained for all patients with a rapid loss of kidney function, especially in the absence of known risk factors for AKI. The use of medicinal herbs with unknown oxalate contents would increase the risk of AON and should be avoided.</p>
</sec>
<sec id="S4" sec-type="data-availability">
<title>Data availability statement</title>
<p>The datasets presented in this study can be found in online repositories. The names of the repository/repositories and accession number(s) can be found in the article/<xref ref-type="supplementary-material" rid="DS1">Supplementary material</xref>.</p>
</sec>
<sec id="S5">
<title>Ethics statement</title>
<p>Ethical review and approval was not required for the study on human participants in accordance with the local legislation and institutional requirements. The patients/participants provided their written informed consent to participate in this study. Written informed consent was obtained from the individual(s) for the publication of any potentially identifiable images or data included in this article.</p>
</sec>
<sec id="S6">
<title>Author contributions</title>
<p>ZZ and JL reviewed the medical literature and clinically managed the patients and manuscript. LW reviewed the relevant histopathology and prepared the figure and manuscript. All authors contributed to the conception, drafting, and final approval of the submitted work.</p>
</sec>
</body>
<back>
<sec id="S7" sec-type="COI-statement">
<title>Conflict of interest</title>
<p>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest.</p>
</sec>
<sec id="S8" sec-type="disclaimer">
<title>Publisher&#x2019;s note</title>
<p>All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article, or claim that may be made by its manufacturer, is not guaranteed or endorsed by the publisher.</p>
</sec>
<sec id="S9" sec-type="supplementary-material">
<title>Supplementary material</title>
<p>The Supplementary Material for this article can be found online at: <ext-link ext-link-type="uri" xlink:href="https://www.frontiersin.org/articles/10.3389/fmed.2022.1063681/full#supplementary-material">https://www.frontiersin.org/articles/10.3389/fmed.2022.1063681/full#supplementary-material</ext-link></p>
<supplementary-material xlink:href="Data_Sheet_1.PDF" id="DS1" mimetype="application/pdf" xmlns:xlink="http://www.w3.org/1999/xlink"/>
</sec>
<ref-list>
<title>References</title>
<ref id="B1"><label>1.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Thompson</surname> <given-names>CS</given-names></name> <name><surname>Weinman</surname> <given-names>EJ</given-names></name></person-group>. <article-title>The significance of oxalate in renal failure.</article-title> <source><italic>Am J Kidney Dis.</italic></source> (<year>1984</year>) <volume>4</volume>:<fpage>97</fpage>&#x2013;<lpage>100</lpage>. <pub-id pub-id-type="doi">10.1016/s0272-6386(84)80055-4</pub-id></citation></ref>
<ref id="B2"><label>2.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Elder</surname> <given-names>TD</given-names></name> <name><surname>Wyngaarden</surname> <given-names>JB</given-names></name></person-group>. <article-title>The biosynthesis and turnover of oxalate in normal and hyperoxaluric subjects.</article-title> <source><italic>J Clin Invest.</italic></source> (<year>1960</year>) <volume>39</volume>:<fpage>1337</fpage>&#x2013;<lpage>44</lpage>. <pub-id pub-id-type="doi">10.1172/JCI104151</pub-id> <pub-id pub-id-type="pmid">13819869</pub-id></citation></ref>
<ref id="B3"><label>3.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Taylor</surname> <given-names>EN</given-names></name> <name><surname>Curhan</surname> <given-names>GC</given-names></name></person-group>. <article-title>Oxalate intake and the risk for nephrolithiasis.</article-title> <source><italic>J Am Soc Nephrol.</italic></source> (<year>2007</year>) <volume>18</volume>:<fpage>2198</fpage>&#x2013;<lpage>204</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2007020219</pub-id> <pub-id pub-id-type="pmid">17538185</pub-id></citation></ref>
<ref id="B4"><label>4.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Glew</surname> <given-names>RH</given-names></name> <name><surname>Sun</surname> <given-names>Y</given-names></name> <name><surname>Horowitz</surname> <given-names>BL</given-names></name> <name><surname>Konstantinov</surname> <given-names>KN</given-names></name> <name><surname>Barry</surname> <given-names>M</given-names></name> <name><surname>Fair</surname> <given-names>JR</given-names></name><etal/></person-group> <article-title>Nephropathy in dietary hyperoxaluria: a potentially preventable acute or chronic kidney disease.</article-title> <source><italic>World J Nephrol.</italic></source> (<year>2014</year>) <volume>3</volume>:<fpage>122</fpage>&#x2013;<lpage>42</lpage>. <pub-id pub-id-type="doi">10.5527/wjn.v3.i4.122</pub-id> <pub-id pub-id-type="pmid">25374807</pub-id></citation></ref>
<ref id="B5"><label>5.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Xie</surname> <given-names>X</given-names></name> <name><surname>Zhang</surname> <given-names>X</given-names></name></person-group>. <article-title>Primary hyperoxaluria.</article-title> <source><italic>N Engl J Med.</italic></source> (<year>2022</year>) <volume>386</volume>:<fpage>976</fpage>. <pub-id pub-id-type="doi">10.1056/NEJMicm2113369</pub-id> <pub-id pub-id-type="pmid">35245013</pub-id></citation></ref>
<ref id="B6"><label>6.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demoulin</surname> <given-names>N</given-names></name> <name><surname>Aydin</surname> <given-names>S</given-names></name> <name><surname>Gillion</surname> <given-names>V</given-names></name> <name><surname>Morelle</surname> <given-names>J</given-names></name> <name><surname>Jadoul</surname> <given-names>M</given-names></name></person-group>. <article-title>Pathophysiology and management of hyperoxaluria and oxalate nephropathy: a review.</article-title> <source><italic>Am J Kidney Dis.</italic></source> (<year>2022</year>) <volume>79</volume>:<fpage>717</fpage>&#x2013;<lpage>27</lpage>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2021.07.018</pub-id> <pub-id pub-id-type="pmid">34508834</pub-id></citation></ref>
<ref id="B7"><label>7.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hopp</surname> <given-names>K</given-names></name> <name><surname>Cogal</surname> <given-names>AG</given-names></name> <name><surname>Bergstralh</surname> <given-names>EJ</given-names></name> <name><surname>Seide</surname> <given-names>BM</given-names></name> <name><surname>Olson</surname> <given-names>JB</given-names></name> <name><surname>Meek</surname> <given-names>AM</given-names></name><etal/></person-group> <article-title>Phenotype-genotype correlations and estimated carrier frequencies of primary hyperoxaluria.</article-title> <source><italic>J Am Soc Nephrol.</italic></source> (<year>2015</year>) <volume>26</volume>:<fpage>2559</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1681/ASN.2014070698</pub-id> <pub-id pub-id-type="pmid">25644115</pub-id></citation></ref>
<ref id="B8"><label>8.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Sas</surname> <given-names>DJ</given-names></name> <name><surname>Enders</surname> <given-names>FT</given-names></name> <name><surname>Mehta</surname> <given-names>RA</given-names></name> <name><surname>Tang</surname> <given-names>X</given-names></name> <name><surname>Zhao</surname> <given-names>F</given-names></name> <name><surname>Seide</surname> <given-names>BM</given-names></name><etal/></person-group> <article-title>Clinical features of genetically confirmed patients with primary hyperoxaluria identified by clinical indication versus familial screening.</article-title> <source><italic>Kidney Int.</italic></source> (<year>2020</year>) <volume>97</volume>:<fpage>786</fpage>&#x2013;<lpage>92</lpage>. <pub-id pub-id-type="doi">10.1016/j.kint.2019.11.023</pub-id> <pub-id pub-id-type="pmid">32093915</pub-id></citation></ref>
<ref id="B9"><label>9.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Lumlertgul</surname> <given-names>N</given-names></name> <name><surname>Siribamrungwong</surname> <given-names>M</given-names></name> <name><surname>Jaber</surname> <given-names>BL</given-names></name></person-group>. <article-title>Secondary oxalate nephropathy: a systematic review.</article-title> <source><italic>Kidney Int Rep.</italic></source> (<year>2018</year>) <volume>3</volume>:<fpage>1363</fpage>&#x2013;<lpage>72</lpage>. <pub-id pub-id-type="doi">10.1016/j.ekir.2018.07.020</pub-id> <pub-id pub-id-type="pmid">30450463</pub-id></citation></ref>
<ref id="B10"><label>10.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Asplin</surname> <given-names>JR</given-names></name></person-group>. <article-title>The management of patients with enteric hyperoxaluria.</article-title> <source><italic>Urolithiasis.</italic></source> (<year>2016</year>) <volume>44</volume>:<fpage>33</fpage>&#x2013;<lpage>43</lpage>. <pub-id pub-id-type="doi">10.1007/s00240-015-0846-5</pub-id> <pub-id pub-id-type="pmid">26645872</pub-id></citation></ref>
<ref id="B11"><label>11.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Siener</surname> <given-names>R</given-names></name> <name><surname>Petzold</surname> <given-names>J</given-names></name> <name><surname>Bitterlich</surname> <given-names>N</given-names></name> <name><surname>Alteheld</surname> <given-names>B</given-names></name> <name><surname>Metzner</surname> <given-names>C</given-names></name></person-group>. <article-title>Determinants of urolithiasis in patients with intestinal fat malabsorption.</article-title> <source><italic>Urology.</italic></source> (<year>2013</year>) <volume>81</volume>:<fpage>17</fpage>&#x2013;<lpage>24</lpage>.</citation></ref>
<ref id="B12"><label>12.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Hueppelshaeuser</surname> <given-names>R</given-names></name> <name><surname>von Unruh</surname> <given-names>GE</given-names></name> <name><surname>Habbig</surname> <given-names>S</given-names></name> <name><surname>Beck</surname> <given-names>BB</given-names></name> <name><surname>Buderus</surname> <given-names>S</given-names></name> <name><surname>Hesse</surname> <given-names>A</given-names></name><etal/></person-group> <article-title>Enteric hyperoxaluria, recurrent urolithiasis, and systemic oxalosis in patients with Crohn&#x2019;s disease.</article-title> <source><italic>Pediatr Nephrol.</italic></source> (<year>2012</year>) <volume>27</volume>:<fpage>1103</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1007/s00467-012-2126-8</pub-id> <pub-id pub-id-type="pmid">22366809</pub-id></citation></ref>
<ref id="B13"><label>13.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Saccomani</surname> <given-names>MD</given-names></name> <name><surname>Pizzini</surname> <given-names>C</given-names></name> <name><surname>Piacentini</surname> <given-names>GL</given-names></name> <name><surname>Boner</surname> <given-names>AL</given-names></name> <name><surname>Peroni</surname> <given-names>DG</given-names></name></person-group>. <article-title>Analysis of urinary parameters as risk factors for nephrolithiasis in children with celiac disease.</article-title> <source><italic>J Urol.</italic></source> (<year>2012</year>) <volume>188</volume>:<fpage>566</fpage>&#x2013;<lpage>70</lpage>. <pub-id pub-id-type="doi">10.1016/j.juro.2012.04.019</pub-id> <pub-id pub-id-type="pmid">22704115</pub-id></citation></ref>
<ref id="B14"><label>14.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Ceulemans</surname> <given-names>LJ</given-names></name> <name><surname>Nijs</surname> <given-names>Y</given-names></name> <name><surname>Nuytens</surname> <given-names>F</given-names></name> <name><surname>De Hertogh</surname> <given-names>G</given-names></name> <name><surname>Claes</surname> <given-names>K</given-names></name> <name><surname>Bammens</surname> <given-names>B</given-names></name><etal/></person-group> <article-title>Combined kidney and intestinal transplantation in patients with enteric hyperoxaluria secondary to short bowel syndrome.</article-title> <source><italic>Am J Transplant.</italic></source> (<year>2013</year>) <volume>13</volume>:<fpage>1910</fpage>&#x2013;<lpage>4</lpage>. <pub-id pub-id-type="doi">10.1111/ajt.12305</pub-id> <pub-id pub-id-type="pmid">23730777</pub-id></citation></ref>
<ref id="B15"><label>15.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Demoulin</surname> <given-names>N</given-names></name> <name><surname>Issa</surname> <given-names>Z</given-names></name> <name><surname>Crott</surname> <given-names>R</given-names></name> <name><surname>Morelle</surname> <given-names>J</given-names></name> <name><surname>Danse</surname> <given-names>E</given-names></name> <name><surname>Wallemacq</surname> <given-names>P</given-names></name><etal/></person-group> <article-title>Enteric hyperoxaluria in chronic pancreatitis.</article-title> <source><italic>Medicine (Baltimore).</italic></source> (<year>2017</year>) <volume>96</volume>:<fpage>e6758</fpage>. <pub-id pub-id-type="doi">10.1097/MD.0000000000006758</pub-id> <pub-id pub-id-type="pmid">28489752</pub-id></citation></ref>
<ref id="B16"><label>16.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Whitson</surname> <given-names>JM</given-names></name> <name><surname>Stackhouse</surname> <given-names>GB</given-names></name> <name><surname>Stoller</surname> <given-names>ML</given-names></name></person-group>. <article-title>Hyperoxaluria after modern bariatric surgery: case series and literature review.</article-title> <source><italic>Int Urol Nephrol.</italic></source> (<year>2010</year>) <volume>42</volume>:<fpage>369</fpage>&#x2013;<lpage>74</lpage>. <pub-id pub-id-type="doi">10.1007/s11255-009-9602-5</pub-id> <pub-id pub-id-type="pmid">19572208</pub-id></citation></ref>
<ref id="B17"><label>17.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Clark</surname> <given-names>B</given-names></name> <name><surname>Baqdunes</surname> <given-names>MW</given-names></name> <name><surname>Kunkel</surname> <given-names>GM</given-names></name></person-group>. <article-title>Diet-induced oxalate nephropathy.</article-title> <source><italic>BMJ Case Rep.</italic></source> (<year>2019</year>) <volume>12</volume>:<fpage>e231284</fpage>. <pub-id pub-id-type="doi">10.1136/bcr-2019-231284</pub-id> <pub-id pub-id-type="pmid">31527218</pub-id></citation></ref>
<ref id="B18"><label>18.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Makkapati</surname> <given-names>S</given-names></name> <name><surname>D&#x2019;Agati</surname> <given-names>VD</given-names></name> <name><surname>Balsam</surname> <given-names>L</given-names></name></person-group>. <article-title>Green smoothie cleanse&#x201D; causing acute oxalate nephropathy.</article-title> <source><italic>Am J Kidney Dis.</italic></source> (<year>2018</year>) <volume>71</volume>:<fpage>281</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1053/j.ajkd.2017.08.002</pub-id> <pub-id pub-id-type="pmid">29203127</pub-id></citation></ref>
<ref id="B19"><label>19.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Monet</surname> <given-names>C</given-names></name> <name><surname>Richard</surname> <given-names>E</given-names></name> <name><surname>Missonnier</surname> <given-names>S</given-names></name> <name><surname>Rebouissoux</surname> <given-names>L</given-names></name> <name><surname>Llanas</surname> <given-names>B</given-names></name> <name><surname>Harambat</surname> <given-names>J</given-names></name></person-group>. <article-title>Secondary hyperoxaluria and nephrocalcinosis due to ethylene glycol poisoning.</article-title> <source><italic>Arch Pediatr.</italic></source> (<year>2013</year>) <volume>20</volume>:<fpage>863</fpage>&#x2013;<lpage>6</lpage>. <pub-id pub-id-type="doi">10.1016/j.arcped.2013.05.011</pub-id> <pub-id pub-id-type="pmid">23827374</pub-id></citation></ref>
<ref id="B20"><label>20.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Fijen</surname> <given-names>L</given-names></name> <name><surname>Weijmer</surname> <given-names>M</given-names></name></person-group>. <article-title>Acute oxalate nephropathy due to high vitamin C doses and exocrine pancreatic insufficiency.</article-title> <source><italic>BMJ Case Rep.</italic></source> (<year>2019</year>) <volume>12</volume>:<fpage>e231504</fpage>. <pub-id pub-id-type="doi">10.1136/bcr-2019-231504</pub-id> <pub-id pub-id-type="pmid">31748360</pub-id></citation></ref>
<ref id="B21"><label>21.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Noonan</surname> <given-names>SC</given-names></name> <name><surname>Savage</surname> <given-names>GP</given-names></name></person-group>. <article-title>Oxalate content of foods and its effect on humans.</article-title> <source><italic>Asia Pac J Clin Nutr.</italic></source> (<year>1999</year>) <volume>8</volume>:<fpage>64</fpage>&#x2013;<lpage>74</lpage>.</citation></ref>
<ref id="B22"><label>22.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Huang</surname> <given-names>J</given-names></name> <name><surname>Huang</surname> <given-names>C</given-names></name> <name><surname>Liebman</surname> <given-names>M</given-names></name></person-group>. <article-title>Oxalate contents of commonly used Chinese medicinal herbs.</article-title> <source><italic>J Tradit Chin Med.</italic></source> (<year>2015</year>) <volume>35</volume>:<fpage>594</fpage>&#x2013;<lpage>9</lpage>. <pub-id pub-id-type="doi">10.1016/s0254-6272(15)30145-x</pub-id></citation></ref>
<ref id="B23"><label>23.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Albersmeyer</surname> <given-names>M</given-names></name> <name><surname>Hilge</surname> <given-names>R</given-names></name> <name><surname>Schr&#x00F6;ttle</surname> <given-names>A</given-names></name> <name><surname>Weiss</surname> <given-names>M</given-names></name> <name><surname>Sitter</surname> <given-names>T</given-names></name> <name><surname>Vielhauer</surname> <given-names>V</given-names></name></person-group>. <article-title>Acute kidney injury after ingestion of rhubarb: secondary oxalate nephropathy in a patient with type 1 diabetes.</article-title> <source><italic>BMC Nephrol.</italic></source> (<year>2012</year>) <volume>13</volume>:<fpage>141</fpage>. <pub-id pub-id-type="doi">10.1186/1471-2369-13-141</pub-id> <pub-id pub-id-type="pmid">23110375</pub-id></citation></ref>
<ref id="B24"><label>24.</label><citation citation-type="journal"><person-group person-group-type="author"><name><surname>Barman</surname> <given-names>AK</given-names></name> <name><surname>Goel</surname> <given-names>R</given-names></name> <name><surname>Sharma</surname> <given-names>M</given-names></name> <name><surname>Mahanta</surname> <given-names>PJ</given-names></name></person-group>. <article-title>Acute kidney injury associated with ingestion of star fruit: acute oxalate nephropathy.</article-title> <source><italic>Indian J Nephrol.</italic></source> (<year>2016</year>) <volume>26</volume>:<fpage>446</fpage>&#x2013;<lpage>8</lpage>. <pub-id pub-id-type="doi">10.4103/0971-4065.175978</pub-id> <pub-id pub-id-type="pmid">27942177</pub-id></citation></ref>
</ref-list>
</back>
</article>